Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
intermittent claudication/glavobolja
Veza se sprema u međuspremnik
Stranica 1 iz 48 rezultatima
[Hypertension, precordial pain, intermittent claudication, severe headache, chills, coma and death].
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Headache and intermittent claudication of the jaw in temporal arteritis.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
[SUBCUTANEOUS INJECTIONS OF CARBON DIOXIDE AND ROYAT THERMAL GASES IN ARTERIAL DISEASES (ANGINA PECTORIS, INTERMITTENT CLAUDICATION, RAYNAUD'S DISEASE, HEADACHE OF HYPERTENSIVES, ETC.)].
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD). Standardized treadmill testing and clinical signs and symptoms of COAD were followed up before
Cilostazol: a novel treatment option in intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Cilostazol is a phosphodiesterase III inhibitor with antiplatelet, antithrombotic and vasodilatory effects. It raises plasma high-density lipoprotein cholesterol levels by approximately 10% and lowers plasma triglycerides by approximately 15%. Eight US/UK randomized, multicentre, double-blind,
Pharmacotherapy of intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Intermittent claudication (IC) is leg muscle pain, cramping and fatigue brought on by exercise and is the primary symptom of peripheral arterial disease. The goals of pharmacotherapy for IC are to increase the walking capacity/quality of life and to decrease rates of amputation. In 1988,
Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Policosanol is a cholesterol-lowering drug with concomitant antiplatelet effects. The present study was undertaken to compare the effects of policosanol and ticlopidine in patients with moderately severe intermittent claudication (IC). The study had a 4-week baseline step, followed by a 20-week
A dose-effect study of beraprost sodium in intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
We compared the efficacy and safety of three doses of beraprost sodium, an epoprostenol analogue, with placebo in the treatment of intermittent claudication (Fontaine's stage II). One hundred sixty-four patients were randomized to receive either placebo, 20 micrograms beraprost sodium (BPS60 group),
Cilostazol for intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND
Peripheral arterial disease (PAD) affects between 4% and 12% of people aged 55 to 70 years, and 20% of people over 70 years. A common complaint is intermittent claudication, characterised by pain in the legs or buttocks that occurs with exercise and which subsides with rest. Compared with
Coital cephalgia and ischaemic muscular work of the lower limbs.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
A case is reported of a patient who presented with coital cephalgia, and in whom an obstructive lesion of the lower aorta was demonstrated. Bicycle ergometry evoked an abnormal pressor response. The condition was cured by restoration of normal circulation. An abnormal pressor response to treadmill
Ergotamine-induced intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
We report about a female patient with intermittent claudication caused by ergotamine. She used ergotamine as a treatment for migraine headaches for more than 4 years. The claudication began 7 month before admission. Colour Doppler sonography and angiography showed severe stenosis of the left
Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
OBJECTIVE
This study evaluated the effects of cilostazol on walking distances in patients with intermittent claudication (IC) caused by peripheral arterial occlusive disease.
METHODS
The study was a multicenter, randomized, double-blind, placebo-controlled trial. Two hundred thirty-nine patients
Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Prostacyclin is an endothelially derived vasodilator and inhibitor of platelet aggregation. Despite its therapeutic potential for peripheral arterial disease, the short half-life and chemical instability are barriers to routine therapy. Accordingly, prostacyclin analogs are being evaluated in
A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND
Peripheral arterial disease (PAD) is a condition in which there is blockage or narrowing of the arteries that carry blood to the legs and arms. It is estimated to affect around 4.5% of people aged between 55 and 74 years within the UK. The most common symptom of PAD is intermittent
[Cilostazol is effective and safe option for the treatment of intermittent claudication. Results of the NOCLAUD study].
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Intermittent claudication can seriously impair the patients' quality of life. Cilostazol was registered in Hungary in 2014. This study aimed to evaluate the efficacy and safety of cilostazol in patients with intermittent claudication. 1405 patients were enrolled to the 6 months, multicenter,
Najkompletnija baza ljekovitog bilja potpomognuta znanošću
- Radi na 55 jezika
- Biljni lijekovi potpomognuti znanošću
- Prepoznavanje bilja slikom
- Interaktivna GPS karta - označite bilje na mjestu (uskoro)
- Pročitajte znanstvene publikacije povezane s vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima
